I g E glycosylation and impact on structure and function: A systematic review
Authors:
- Alexandra J. McCrawAMAlexandra J. McCraw
- Lais C. G. F. PalharesLPLais C. G. F. Palhares
- Jenifer L. HendelJHJenifer L. Hendel
- Richard A. GardnerRGRichard A. Gardner
- Aida SantaolallaASAida Santaolalla
- Silvia CrescioliSCSilvia Crescioli
- James McDonnellJames McDonnell
- Mieke Van HemelrijckMieke Van Hemelrijck
- Alicia ChenowethACAlicia Chenoweth
- Daniel I. R. SpencerDSDaniel I. R. Spencer
- Gerd K. WagnerGerd K. Wagner
- Sophia N. KaragiannisSophia N. Karagiannis
Open Access
Abstract
The impact of human IgE glycosylation on structure, function and disease mechanisms is not fully elucidated, and heterogeneity in different studies renders drawing conclusions challenging. Previous reviews discussed IgE glycosylation focusing on specific topics such as health versus disease, FcεR binding or impact on function. We present the first systematic review of human IgE glycosylation conducted utilizing the PRISMA guidelines. We sought to define the current consensus concerning the roles of glycosylation on structure, biology and disease. Despite diverse analytical methodologies, source, expression systems and the sparsity of data on IgE antibodies from non‐allergic individuals, collectively evidence suggests differential glycosylation profiles, particularly in allergic diseases compared with healthy states, and indicates functional impact, and contributions to IgE‐mediated hypersensitivities and atopic diseases. Beyond allergic diseases, dysregulated terminal glycan structures, including sialic acid, may regulate IgE metabolism. Glycan sites such as N394 may contribute to stabilizing IgE structure, with alterations in these glycans likely influencing both structure and IgE‐FcεR interactions. This systematic review therefore highlights critical IgE glycosylation attributes in health and disease that may be exploitable for therapeutic intervention, and the need for novel analytics to explore pertinent research avenues.Keywords
Funding Information
- Worldwide Cancer Research (24‐0087)
- Cancer Research UK (C30122/A11527)
- Cancer Research UK (C30122/A15774)
- British Skin Foundation (006/R/22)
- Breast Cancer Now (KCL‐BCN‐Q3)
- Medical Research Council (MR/R015643/1)
This publication has 106 references indexed in Scilit:
- Antibody glycosylation in autoimmune diseasesAutoimmunity Reviews, 2021
- Immunoglobulin Glycosylation Effects in Allergy and ImmunityCurrent Allergy and Asthma Reports, 2016
- IgE and mast cells in host defense against parasites and venomsSeminars in Immunopathology, 2016
- The Art of Destruction: Optimizing Collision Energies in Quadrupole-Time of Flight (Q-TOF) Instruments for Glycopeptide-Based GlycoproteomicsJournal of the American Society for Mass Spectrometry, 2016
- Glycoproteomic studies of IgE from a novel hyper IgE syndrome linked to PGM3 mutationGlycoconjugate Journal, 2015
- Basis of the 1:1 stoichiometry of the high affinity receptor FcεRI-IgE complexEuropean Biophysics Journal, 1997
- Purification and characterization of recombinant human IgE Fcϵ fragment produced in mouse L cellsMolecular Immunology, 1987
- Purification and characterization of IgE produced by human myeloma cell line, U266Molecular Immunology, 1986
- Lectin-binding ability of immunoglobulin E and its partipication in triggering of mast cellsFolia Microbiologica, 1985
- Structural studies of oligosaccharides of rat IgE and reexamination of the high-mannose oligosaccharide of human IgEArchives of Biochemistry and Biophysics, 1983